ABOS
Acumen Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Acumen Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Acumen Pharmaceuticals, Inc.
0.22
−2.07 · −90.48%
post 0.22 +2.16%
Linked news
News
Expected move
No implied move.
No implied move.
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $56.1M | 43.81% | 0.00% | |
| 2 | Sands Capital VenturesSands Capital Ventures | $9.9M | 7.76% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $6.6M | 5.20% | +1296.38% | |
| 4 | Alyeska Investment GroupAlyeska Investment | $6.6M | 5.12% | 0.00% | |
| 5 | Franklin ResourcesFranklin Resources | $6.2M | 4.81% | 0.00% | |
| 6 | ADAR1 Capital ManagementADAR1 | $5.6M | 4.41% | −2.09% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $4.5M | 3.49% | +11.01% | |
| 8 | Knollwood Investment AdvisoryKnollwood Investment Advisory | $4.3M | 3.40% | 0.00% | |
| 9 | Geode Capital ManagementGeodeindex-like | $3.0M | 2.38% | +174.33% | |
| 10 | Ikarian CapitalIkarian Capital | $2.8M | 2.20% | 0.00% | |
| 11 | Hudson Bay Capital ManagementHudson Bay | $2.5M | 1.99% | −1.44% | |
| 12 | Pathstone HoldingsPathstone | $2.3M | 1.79% | 0.00% | |
| 13 | Renaissance TechnologiesRenaissance Technologies | $1.8M | 1.41% | +42.43% | |
| 14 | Two Sigma InvestmentsTwo Sigma | $1.7M | 1.30% | +17.35% | |
| 15 | State StreetState Streetindex-like | $1.6M | 1.25% | +295.79% | |
| 16 | Northern TrustNorthern Trustindex-like | $963,187 | 0.75% | +379.64% | |
| 17 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $856,523 | 0.67% | new | |
| 18 | Dimensional Fund AdvisorsDimensional | $778,969 | 0.61% | +143.46% | |
| 19 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $777,611 | 0.61% | +46.19% | |
| 20 | Bank of AmericaBank of America | $733,665 | 0.57% | −14.19% | |
| 21 | Boothbay Fund ManagementBoothbay Fund | $728,942 | 0.57% | 0.00% | |
| 22 | Acadian Asset ManagementAcadian | $722,000 | 0.56% | +45.46% | |
| 23 | Nomura HoldingsNomura | $506,531 | 0.40% | new | |
| 24 | Susquehanna International GroupSusquehanna International | $495,296 | 0.39% | −74.00% | |
| 25 | Goldman Sachs GroupGoldman Sachs | $491,085 | 0.38% | −11.01% |
96 managers report $127.9M of Acumen Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 9 of them hold 80% of it; RA Capital Management is largest at 43.81%.